Biosimilars and Interchangeable Biologics: Tactical Elements - Image 1

£49.99

CRC Press Biosimilars and Interchangeable Biologics: Tactical Elements

Name: Biosimilars and Interchangeable Biologics: Tactical Elements
Brand: CRC Press
Price: 47.31 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 35 days • 35 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 35 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £47 (25 days, 71.4%)

Price range: £47 - £50

Price levels: 2 different prices over 35 days

Description

What’s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Tactical Elements explores the development and manufacturing of biosimilars and targets challenges surrounding the creation of these products. This includes manufacturing, production costs, and intellectual property barriers, particularly in regulated markets (regulatory agencies are still in the process of developing guidelines). It addresses the complexity of biological drugs, and it discusses specific structural elements vital to the functionality, immunogenicity, and safety of biosimilar products. Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume provides an overall understanding of the hurdles, difficulties, and practicalities of developing a strong plan. It introduces a step-by-step approach for creating a strategy that helps develop and manufacture a biosimilar product while reducing overall production costs and meeting the requirements of biosimilarity based on analytical and functional, pharmacokinetic, pharmacodynamic (where applicable), and nonclinical toxicology or toxicokinetic similarity (where appropriate) while remaining competitive in the market.

Product Specifications

Brand: CRC Press
Format: paperback
ASIN: 1032652349
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 02 October 2023
Listed Since: 17 August 2023

Barcode

No barcode data available

CRC Press Biosimilars and Interchangeable Biologics: Tactical Elements

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Biosimilars Development Strategies: Fast to Market Approaches

Biosimilars and Interchangeable Biologics: Strategic Elements

Biopharmaceuticals: Challenges and Opportunities

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Handbook of Bioequivalence Testing (Drugs and the Pharmaceutical Sciences)

CRC Press - Biosimilar Drug Product Development Book

Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

mRNA Therapeutics: Fast-to-Market Strategies

Wiley - Biological Drug Products: Development and Strategies

Developability of Biotherapeutics: Computational Approaches

Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series)

Producing Biomolecular Substances with Fermenters, Bioreactors, and Biomolecular Synthesizers

Handbook of Cell and Gene Therapy: From Proof-of-Concept through Manufacturing to Commercialization

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

ASHP Biosimilars and Biologics - Implementation and Monitoring

Pharmaceutical Product Development: Insights Into Pharmaceutical Processes, Management and Regulatory Affairs